Voyager Life #VOY – Result of GM, Director-PDMR Shareholding, Issue of Equity & Warrants

Voyager is pleased to announce that at the General Meeting held earlier today, all resolutions were duly passed.

Issue of Equity

Following shareholder approval at the General Meeting the Company has issued 22,239,150 new ordinary shares (being the Second Tranche Shares). The Company has also issued 14,407,803 Investor Warrants and 900,000 Broker Warrants, in aggregate 15,307,803 Warrants have been issued in connection with the Fundraise.

Director Participation & Director / PDMR Shareholding

As part of the Fundraise, Eric Boyle, Non-Executive Chairman, and Fetlar Capital Limited (a company controlled by Nick Tulloch, Chief Executive Officer and his spouse) have subscribed, in aggregate, for £50,000 of Fundraise Shares (“Director Participation”) as set out in the table below. 

^*Participation made through Fetlar Capital Limited (a company controlled by Nick Tulloch, Chief Executive Officer and his spouse)

Related Party Transaction

The Director Participation (the “Transaction”) is a related party transaction for the purposes of Rule 4.6 of the AQSE Growth Market Access Rulebook. Jill Overland, the director of Voyager independent of the Transaction confirms that, having exercised reasonable care, skill and diligence, the Transaction is fair and reasonable insofar as the shareholders of Voyager are concerned. 

Admission

Application has been made for the Second Tranche Shares to be admitted to trading on the Aquis Stock Exchange AQSE Growth Market. Second Admission is expected to occur at 8:00 am on or around 19 July 2024. 

Total voting rights

Following Second Admission, the Company’s enlarged share capital will comprise 43,218,494 ordinary shares of 1 pence each. Therefore, the total number of voting rights in the Company will be 43,218,494. This figure may be used by shareholders as the denominator for calculations by which they will determine if they are required to notify their interest in the Company, or a change to their interest in the Company, under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the circular published by the Company on 1 July 2024.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

ENDS

Enquiries:

FORWARD LOOKING STATEMENTS

This announcement includes “forward-looking statements” which include all statements other than statements of historical facts, including, without limitation, those regarding the Company’s financial position, business strategy, plans and objectives of management for future operations, or any statements preceded by, followed by or that include the words “targets”, “believes”, “expects”, “aims”, “intends”, “will”, “may”, “anticipates”, “would”, “could” or “similar” expressions or negatives thereof. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors beyond the Company’s control that could cause the actual results, performance or achievements of the Company to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company’s present and future business strategies and the environment in which the Company will operate in the future. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company’s expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based unless required to do so by applicable law.